Table 6P.1b - List of ICD-10-PCS procedure code mapping between Version 38 and Version 39 of the MS-DRGs 			
Deleted  (V38)                                   ICD-10-PCS          Procedure Code	Code Description 	Mapped  (V39)                                   ICD-10-PCS                       Procedure Code	Code Description 
XW033C3	"Introduction of engineered autologous chimeric antigen receptor t-cell immunotherapy into peripheral vein, percutaneous approach, new technology group 3"	XW033C7	"Introduction of autologous engineered chimeric antigen receptor t-cell immunotherapy into peripheral vein, percutaneous approach, new technology group 7"
XW043C3	"Introduction of engineered autologous chimeric antigen receptor t-cell immunotherapy into central vein, percutaneous approach, new technology group 3"	XW043C7	"Introduction of autologous engineered chimeric antigen receptor t-cell immunotherapy into central vein, percutaneous approach, new technology group 7"
XW23346	"Transfusion of brexucabtagene autoleucel immunotherapy into peripheral vein, percutaneous approach, new technology group 6"	XW033M7	"Introduction of brexucabtagene autoleucel immunotherapy into peripheral vein, percutaneous approach, new technology group 7"
XW23376	"Transfusion of lisocabtagene maraleucel immunotherapy into peripheral vein, percutaneous approach, new technology group 6"	XW033N7	"Introduction of lisocabtagene maraleucel immunotherapy into peripheral vein, percutaneous approach, new technology group 7"
XW24346	"Transfusion of brexucabtagene autoleucel immunotherapy into central vein, percutaneous approach, new technology group 6"	XW043M7	"Introduction of brexucabtagene autoleucel immunotherapy into central vein, percutaneous approach, new technology group 7"
XW24376	"Transfusion of lisocabtagene maraleucel immunotherapy into central vein, percutaneous approach, new technology group 6"	XW043N7	"Introduction of lisocabtagene maraleucel immunotherapy into central vein, percutaneous approach, new technology group 7"
